The gastrointestinal Microbiota in Cancer

Gastrointestinal Microbiology

Volumn , Issue , 2006, Pages 225-236

  Heavey, Patricia M ^a   Rowland, Ian R ^b   Rafter, Joseph J ^c  

^a KINGSTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882493696     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (68)

1. Cummings JH, MacFarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70:443-459.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorgenesis. Cell 1990; 61:759-767.
3. Draser BS. The bacterial flora of the intestine. In: Rowland IR, ed. The role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1988:23-38.
4. Hill MJ. In: Hill MJ, ed. The role of Gut Bacteria in Human Toxicology and Pharmacology. London: Taylor and Francis, 1995.
5. Hill MJ. Gut flora and cancer in humans and laboratory animals. In: Rowland IR, ed. The role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1988:461-502.
6. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomised, controlled study. Ann Int Med 1992; 116:705-708.
7. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994; 73:2691-2694.
8. Kikuchi S, Wada O, Nakajaima T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research group on prevention of gastric carcinoma among young adults. Cancer 1995; 75:2789-2793.
9. Atherton JC. H. pylori virulence factors. Br Med Bull 1998; 54:105-120.
10. Moss SF. The carcinogenic effect of H. pylori on the gastric epithelial cell. J Physiol Pharmacol 1999; 50:847-856.
11. Yao YL, Xu B, Song YG, et al. Effect of Helicobacter pylori infection on gastric mucosal cell proliferation in mongolian gerbils. Di Yi Junyi Daxue Xuebao 2002; 22:348-350.
12. Arends MJ. How do cancer cells die? Apoptosis and its role in neoplastic progression. In: Leake R, Gore M, Ward RH, eds. The Biology of Gynaecological Cancer. Royal College of Obstetricians and Gynaecological Press, London, 1995:73-91.
13. Cho KR, Vogelstein B. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem 1992; 16G:137-141.
14. Zhang ZW, Patchett SE, Farthing MJ. Role of Helicobacter pylori and p53 in regulation of gastric epithelial cell cycle phase progression. Dig Dis Sci 2002; 47:987-995.
15. Wagner S, Beil W, Westermann J, et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology 1997; 113:1836-1847.
16. Wang J, Chi DS, Kalin GB, et al. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci 2002; 47:107-113.
17. Shirin H, Hibshoosh H, Kawabata Y, et al. P16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis. Helicobacter 2003; 8:66-71.
18. Correa P, Malcolm G, Schmidt B, et al. Antioxidant micronutrients and gastric cancer. Aliment Pharmacol Ther 1998; 12:73-82.
19. Zhang HM, Wakisaka N, Maeda O, Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer 1997; 80:1897-1903.
20. Zhang ZW, Abdullahi M, Farthing MJ. Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori. Gut 2002; 50:165-169.
21. Kaaks R, Tuyns AJ, Haelterman M, Riboli E. Nutrient intake patterns and gastric cancer risk: a case control study in Belgium. Int J Cancer 1998; 78:415-420.
22. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C and other risk factors. J Natl Cancer Inst 2000; 92:1607-1612.
23. Guo X, Wang L, Yuan Y. Association between Helicobacter pylori cagA strain infection and expression of cyclooxygenase 2 in gastric carcinoma. Chin Med J 2002; 82:868-871.
24. Breuer NF, Dommes P, Jaekel S, Goebell H. Fecal bile acid excretion pattern in colonic cancer patients. Dig Dis Sci 1985; 30:852-859.
25. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection, and non-steroidal antiinflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359:14-22.
26. Blaser MJ. Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in microecology in the modern era. Gut 1998; 43:721-727.
27. Logan RP, Walker MM. ABC of the upper gastrointestinal tract: epidemiology and diagnosis of Helicobacter pylori infection. BMJ 2001; 323:920-922.
28. Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60:203-209.
29. Mitsuoka T. Recent trends in research on intestinal flora. Bifidobacteria Microflora 1982; 3:3-24.
30. Draser BS. The bacterial flora of the intestine. In: Rowland IR, ed. The Role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1998:23-38.
31. Rowland IR, ed. Role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1988.
32. Rowland IR. Toxicology of the colon: role of the intestinal flora. In: Gibson GR, MacFarlane GT, eds. Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology. Boca Raton: CRC Press, 1995:155-174.
33. Orrhage K, Sillerstrom E, Gustafsson JA, et al. Binding of the mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat Res 1994; 311:239-248.
34. Fassano A. Cellular microbiology: can we learn cell physiology from microorganisms? Am J Physiol 1999; 276:C765-C776.
35. Hill MJ, Draser BS, Hawksworth G, et al. Bacteria and aetiology of cancer of the large bowel. Lancet 1971; i:95-100.
36. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61:3202-3207.
37. Kanazawa K, Konishi F, Mitsuoka T, et al. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer 1996; 77:1701-1706.
38. Reddy BS, Narisawa T, Maronpot R, et al. Animal models for the study of dietary factors and cancer of the large bowel. Cancer Res 1975; 35:3421-3426.
39. Reddy BS, Weisburger JH, Narisawa T, Wynder EL. Colon carcinogenesis in germ-free rats with dimethylhydrazine, and N-nitrosamines in health and gastroduodenal disease. Lancet 1974; ii:550-552.
40. Kado S, Uchida K, Funabashi H, et al. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor b chain and p53 doubleknockout mice. Cancer Res 2001; 61:2395-2398.
41. Ellmerich S, Djouder N, Schőller M, Klein JP. Production of cytokines by monocytes, epithelial and endothelial cells activated by Streptococcus bovis. Cytokine 2000; 12:26-31.
42. Horie H, Kanawawa K, Okada M, et al. Effects of intestinal bacteria on the development of colonic neoplasm: an experimental study. Eur J Cancer Prev 1999; 8:237-245.
43. Rowland IR, Gangolli SD. Role of gastro-intestinal microflora in the metabolic and toxicological activities of xenobiotics. In: Ballentyne B, Marrs, TC, Syveron T eds. General and Applied Toxicology 1999; P562-576.
44. Cole CB, Fuller R, Mallett AK, Rowland IR. The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. J Appl Bacteriol 1985; 58:549-553.
45. Saito Y, Takano T, Rowland IR. Effects of soybean oligosaccharides on the human gut microflora in in vitro culture. Microb Ecol Health Dis 1992; 5:105-110.
46. Tadaka H, Hirooka T, Hiramatsu Y, Yamamoto M. Effects of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res 1982; 42:331-334.
47. Grasten SM, Juntunen KS, Poutanen KS, et al. Rye bread improves bowel function and decreases the concentrations of some compounds that are putative colon cancer risk markers in middle-aged women and men. J Nutr 2000; 130:2215-2221.
48. Kim DH, Jin YH. Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arch Pharmacol Res 2001; 24:564-567.
49. Eriyamremu GE, Osagie VE, Alufa OI, et al. Early biochemical events in mice exposed to cycas and fed a nigerian-like diet. Ann Nutr Metab 1995; 39:42-51.
50. Rowland IR, Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human fecal microflora. J Appl Bacteriol 1993; 74:667-674.
51. Mallet AK, Rowland IR. Factors affecting the gut microflora. In: Rowland IR, ed. Role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1988:347-382.
52. Hughes R, Cross AJ, Pollock JR, Bingham S. Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis 2001; 22:199-202.
53. Silvester KR, Bingham SA, Pollock JR, et al. Effect of meat and resistant starch on fecal excretion of apparent N-nitroso compounds and ammonia from the human large bowel. Nutr Cancer 1997; 29:13-23.
54. MacDonald IA, Sutherland JD, Cohen BI, Mosbach EH. Effect of bile acid oxazoline derivatives on microorganisms participating in 7 alpha-hydroxyl epimenzation of primary bile acids. J Lipid Res 1983; 24:1150-1559.
55. Gill CI, Rowland IR. Diet and cancer: assessing the risk. Br J Nutr 2002; 88:S73-S87.
56. Imray CHE, Radley S, Davis A, et al. Fecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut 1992; 33:1239-1245.
57. Stadler J, Yeung KS, Furrer R, et al. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett 1988; 38:315-320.
58. Owen RW. Feacal steroids and colorectal carcinogenesis. Scand J Gastroenterol 1997; 222:76-82.
59. de Kok TM, van Maanen JM. Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat Res 2000; 463:53-101.
60. Silvi S, Rumney CJ, Cresci A, Rowland IR. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with feces from Italian and U.K. donors. J Appl Microbiol 1999; 86:521-530.
61. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994; 1:S35-S38.
62. Bird AR, Brown IL, Topping DL. Starches, resistant starches, the gut microflora and human health. Curr Issues Intest Microbiol 2000; 1:25-37.
63. Archer S, Meng S, Shei A, Hodin RA. P21WAFI is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 1998; 95:6791-6796.
64. Ishizuka S, Sonoyama K, Kassai T. Changes in the number and apoptosis of epithelial cells in the colorectum of wheat bran-fed rats soon after administering 1,2-dimethylhydrazine. Biosci Biotechnol Biochem 1997; 61:1337-1341.
65. Xu J, Bjursell MK, Himrod J, et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003; 299:2074-2076.
66. Smith JG, Yokoyama WH, German BG. Butyric acid from the diet: actions at the level of gene expression. Clin Rev Food Sci 1998; 38:259-297.
67. Hodin RA, Meng S, Archer S. Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ 1996; 7:647-653.
68. Rafter J, Govers M, Martel P, et al. PASSCLAIM—Diet-related cancer. European Journal of Nutrition,. 2004; 43:II47-II84.